These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11168523)

  • 1. Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation.
    Garderet L; Bittencourt H; Kaliski A; Daniel M; Ribaud P; Socié G; Gluckman E
    Eur J Haematol; 2001 Feb; 66(2):137-9. PubMed ID: 11168523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation.
    Collins RH; Piñeiro LA; Agura ED; Fay JW
    Bone Marrow Transplant; 1998 Mar; 21(6):627-8. PubMed ID: 9580345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease.
    Castagna L; Nozza A; Bertuzzi A; Siracusano L; Timofeeva I; Santoro A
    Bone Marrow Transplant; 2001 Dec; 28(12):1155-6. PubMed ID: 11803359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
    Murase K; Matsunaga T; Sato T; Kuribayashi K; Kogawa K; Kawano Y; Okamoto T; Takayama T; Watanabe H; Niitsu Y; Hirayama Y
    Int J Clin Oncol; 2003 Dec; 8(6):391-4. PubMed ID: 14663643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia].
    Okamura K; Ikeda T; Shimakura Y; Yoshiba F; Kishi K; Ando K; Hotta T
    Rinsho Ketsueki; 2005 Jul; 46(7):527-31. PubMed ID: 16440747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.
    Curtin NJ; Schwarer AP
    Clin Lab Haematol; 2005 Jun; 27(3):206-8. PubMed ID: 15938729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.
    de Lavallade H; Faucher C; Fürst S; El-Cheikh J; Vey N; Coso D; Bouabdallah R; Stoppa AM; Gastaut JA; Blaise D; Mohty M
    Bone Marrow Transplant; 2006 Apr; 37(7):709-10. PubMed ID: 16474410
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
    Childs R; Chernoff A; Contentin N; Bahceci E; Schrump D; Leitman S; Read EJ; Tisdale J; Dunbar C; Linehan WM; Young NS; Barrett AJ
    N Engl J Med; 2000 Sep; 343(11):750-8. PubMed ID: 10984562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatched unrelated cord blood transplantation in a patient with T-cell prolymphocytic leukemia.
    Tanimoto TE; Hirano A; Nagafuji K; Yamasaki S; Hashiguchi M; Okamura T; Kamezaki K; Takase K; Numata A; Miyamoto T; Fukuda T; Harada M
    Leukemia; 2005 Apr; 19(4):679-81. PubMed ID: 15690068
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
    Guillaume T; Beguin Y; Tabrizi R; Nguyen S; Blaise D; Deconinck E; Redjoul R; Cornillon J; Guillerm G; Contentin N; Sirvent A; Turlure P; Salmon A; Huynh A; François S; Peffault de Latour R; Yakoub-Agha I; Mohty M
    Eur J Haematol; 2015 Mar; 94(3):265-9. PubMed ID: 25130897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
    Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire.
    Malard F; Milpied N; Blaise D; Chevallier P; Michallet M; Lioure B; Clément L; Hicheri Y; Cordonnier C; Huynh A; Yakoub-Agha I; Peffault de Latour R; Mohty M
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1059-67. PubMed ID: 25708220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation].
    Wu B; Guo K; Song Z; Yan D; Yang Y; Xiao L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):194-7. PubMed ID: 12133456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.